AXDX - Accelerate Diagnostics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/2015
Total Revenue4,177246147
Cost of Revenue1,002--
Gross Profit3,175246147
Operating Expenses
Research Development22,30129,56427,142
Selling General and Administrative45,05837,18318,554
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-64,184-66,501-45,549
Income from Continuing Operations
Total Other Income/Expenses Net64939455
Earnings Before Interest and Taxes-63,535-66,107-45,494
Interest Expense--4
Income Before Tax-63,535-66,107-45,498
Income Tax Expense493267-
Minority Interest---
Net Income From Continuing Ops-64,028-66,374-45,498
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-64,028-66,374-45,498
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-64,028-66,374-45,498